Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 92651-92700 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05141474
Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors
EARLY_PHASE1Recruiting
10 participants
Started: Oct 28, 2021 · Completed: Jan 1, 2027
2 conditions2 sponsors1 location
NCT04943341
Evaluation of the Triamcinolone -Acetonide Therapy for the Treatment of the Medial Plica Syndrome
NAActive, not recruiting
30 participants
Started: Oct 28, 2021 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT04989712
MOReS Freestyle Libre Validation Study
NARecruiting
10 participants
Started: Oct 28, 2021 · Completed: Sep 30, 2024
3 conditions1 sponsor1 location
NCT05021536
Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment
PHASE3Active, not recruiting
664 participants
Started: Oct 28, 2021 · Completed: Jan 1, 2026
1 condition1 sponsor69 locations
NCT05122988
Facing Adverse Childhood Experiences
N/AActive, not recruiting
2,606 participants
Started: Oct 28, 2021 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT05096273
Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES
NARecruiting
68 participants
Started: Oct 28, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04867954
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
N/ARecruiting
141 participants
Started: Oct 28, 2021 · Completed: Apr 30, 2026
2 conditions2 sponsors1 location
NCT04493645
Ankle Instability Using Foot Intensive Rehabilitation
NAActive, not recruiting
150 participants
Started: Oct 28, 2021 · Completed: Dec 1, 2025
2 conditions4 sponsors1 location
NCT05157776
A Phase III Trial of Neoadjuvant Sintilimab and Chemotherapy for NSCLC Harboring No Driver Mutations
PHASE3Recruiting
72 participants
Started: Oct 28, 2021 · Completed: Oct 31, 2025
3 conditions1 sponsor1 location
NCT05128630
Chemo-immunotherapy, Hypo-fractionated RT and Maintenance Immunotherapy for Stage III NSCLC.
PHASE2Recruiting
45 participants
Started: Oct 28, 2021 · Completed: Nov 28, 2025
1 condition1 sponsor1 location
NCT06669884
Use of Determine Learning-based Cardiodynamicsgram (CDG) for Rapid and Precise Stratification of Chest Pain in Emergency Department
N/ARecruiting
8,000 participants
Started: Oct 28, 2021 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT05131035
Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk
NARecruiting
54 participants
Started: Oct 28, 2021 · Completed: May 31, 2026
3 conditions2 sponsors1 location
NCT05325632
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
PHASE2Recruiting
53 participants
Started: Oct 28, 2021 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT06773039
Assessment of Different Therapeutic Strategies in Patients With Head and Neck Neoplasms Treated With Radiotherapy
N/ARecruiting
3,000 participants
Started: Oct 28, 2021 · Completed: Dec 15, 2030
1 condition1 sponsor1 location
NCT05139225
A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple Myeloma
PHASE1Active, not recruiting
7 participants
Started: Oct 28, 2021 · Completed: Oct 31, 2025
1 condition2 sponsors7 locations
NCT05048797
A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations
PHASE3Recruiting
450 participants
Started: Oct 28, 2021 · Completed: Jul 30, 2027
1 condition2 sponsors163 locations
NCT05068752
Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer
PHASE2Active, not recruiting
12 participants
Started: Oct 28, 2021 · Completed: Dec 30, 2024
1 condition3 sponsors1 location
NCT05009459
eVISualisation of Physical Activity and Pain (eVIS) for Patients With Chronic Pain
NARecruiting
280 participants
Started: Oct 28, 2021 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT04744454
Post Marketing Surveillance (PMS) Study of Cresemba in Korea.
N/ARecruiting
600 participants
Started: Oct 28, 2021 · Completed: Jan 30, 2026
2 conditions1 sponsor1 location
NCT04942080
Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)
NARecruiting
260 participants
Started: Oct 28, 2021 · Completed: Apr 28, 2026
4 conditions2 sponsors1 location
NCT05043090
Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC
PHASE3Active, not recruiting
148 participants
Started: Oct 28, 2021 · Completed: Oct 30, 2025
1 condition1 sponsor139 locations
NCT06307301
Study in ALS With Abatacept & IL-2
PHASE1Active, not recruiting
5 participants
Started: Oct 28, 2021 · Completed: Oct 17, 2024
1 condition1 sponsor1 location
NCT05755074
Ablation of Typical Right Atrial Flutter
NARecruiting
40 participants
Started: Oct 28, 2021 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT04302324
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
PHASE2Active, not recruiting
9 participants
Started: Oct 28, 2021 · Completed: Dec 28, 2027
3 conditions2 sponsors1 location
NCT05193227
Sustained Release Lidocaine for the Treatment of Postoperative Pain
PHASE2Recruiting
120 participants
Started: Oct 27, 2021 · Completed: May 27, 2026
2 conditions2 sponsors2 locations
NCT05372172
Tennessee Alzheimer's Project
N/ARecruiting
1,000 participants
Started: Oct 27, 2021 · Completed: Dec 31, 2025
7 conditions2 sponsors1 location
NCT04141020
Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms
PHASE2Recruiting
80 participants
Started: Oct 27, 2021 · Completed: Nov 1, 2026
1 condition2 sponsors1 location
NCT06159907
Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Gynecological Tumors.
N/ARecruiting
380 participants
Started: Oct 27, 2021 · Completed: Dec 27, 2024
1 condition1 sponsor1 location
NCT05029635
Phase III Study on HMPL-523 for Treatment of ITP
PHASE3Active, not recruiting
272 participants
Started: Oct 27, 2021 · Completed: May 30, 2025
1 condition1 sponsor37 locations
NCT04763577
Bradykinin-degradating Enzymes Activities in Angiotensin-Converting Enzyme Inhibitors-associated Angioedema
N/ARecruiting
243 participants
Started: Oct 27, 2021 · Completed: Oct 26, 2025
1 condition3 sponsors4 locations
NCT05022342
Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world
N/ARecruiting
200 participants
Started: Oct 27, 2021 · Completed: Sep 30, 2025
1 condition1 sponsor8 locations
NCT05096338
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
N/AActive, not recruiting
200 participants
Started: Oct 27, 2021 · Completed: Nov 30, 2029
4 conditions2 sponsors1 location
NCT05117242
Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer
PHASE2Active, not recruiting
125 participants
Started: Oct 27, 2021 · Completed: Mar 31, 2027
1 condition2 sponsors42 locations
NCT05142462
Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup
N/AActive, not recruiting
120 participants
Started: Oct 27, 2021 · Completed: Jul 31, 2032
6 conditions1 sponsor4 locations
NCT06586177
Understanding the 'Durable Effect' Concept of B-cell Modulating Therapies
N/ARecruiting
100 participants
Started: Oct 27, 2021 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT05091190
Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers
NAActive, not recruiting
75 participants
Started: Oct 27, 2021 · Completed: Dec 11, 2026
2 conditions1 sponsor2 locations
NCT05049993
Pyrocarbon Clinical Follow-up Study
N/AActive, not recruiting
76 participants
Started: Oct 27, 2021 · Completed: Dec 31, 2027
3 conditions1 sponsor8 locations
NCT05075590
Coronary Access After Supra-Annular THV Implantation
NARecruiting
50 participants
Started: Oct 27, 2021 · Completed: Jul 31, 2024
2 conditions3 sponsors4 locations
NCT05181592
Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.
PHASE3Active, not recruiting
70 participants
Started: Oct 27, 2021 · Completed: Feb 28, 2027
1 condition2 sponsors13 locations
NCT04812717
Prevention of Low Blood Pressure After Cardiac Surgery in Heart Failure Patients With a Filter Called CytoSorb.
NARecruiting
36 participants
Started: Oct 27, 2021 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT05090566
MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma
PHASE2Active, not recruiting
34 participants
Started: Oct 27, 2021 · Completed: Feb 19, 2026
1 condition1 sponsor33 locations
NCT04988386
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
PHASE3Active, not recruiting
389 participants
Started: Oct 27, 2021 · Completed: May 15, 2028
1 condition1 sponsor72 locations
NCT04712097
A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma
PHASE3Active, not recruiting
478 participants
Started: Oct 27, 2021 · Completed: Dec 31, 2029
1 condition1 sponsor112 locations
NCT04981834
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer
NARecruiting
196 participants
Started: Oct 27, 2021 · Completed: Oct 27, 2026
9 conditions2 sponsors1 location
NCT04952220
Exploratory Study of Ultrasound Signs of Native Septic Arthritis of the Knee
N/ARecruiting
30 participants
Started: Oct 27, 2021 · Completed: Oct 31, 2025
3 conditions1 sponsor7 locations
NCT04983095
Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
NARecruiting
118 participants
Started: Oct 27, 2021 · Completed: Dec 31, 2033
3 conditions9 sponsors7 locations
NCT05091021
Skeletal Effects of Chronic Night Shift
N/AActive, not recruiting
40 participants
Started: Oct 27, 2021 · Completed: Feb 28, 2026
2 conditions2 sponsors1 location
NCT05078931
A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC Patients
PHASE2Active, not recruiting
35 participants
Started: Oct 27, 2021 · Completed: Dec 30, 2026
1 condition2 sponsors1 location
NCT04460989
Assessment of Patient Satisfaction After Arthroplasty: A Comparative Study by Implant Type
N/ARecruiting
480 participants
Started: Oct 27, 2021 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05001477
Customized TULSA-PRO Ablation Registry
N/ARecruiting
1,000 participants
Started: Oct 27, 2021 · Completed: Oct 31, 2061
3 conditions1 sponsor5 locations